Cocaine Choice in Humans During d-Amphetamine Maintenance
Authors:
- Craig R. RushCRCraig R. Rush
- William W. StoopsWSWilliam W. Stoops
- Rajkamur J. SevakRSRajkamur J. Sevak
- Lon R. HaysLHLon R. Hays
- 1 April 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 30 (2) , 152-159
Abstract
The results of preclinical laboratory experiments and clinical trials indicate that agonist replacements such as d-amphetamine may be a viable option for managing cocaine dependence. This study determined the effects of d-amphetamine maintenance on cocaine choice behavior in human participants. We predicted that d-amphetamine maintenance would reduce cocaine choice. Nine cocaine-dependent participants completed the study. Two d-amphetamine maintenance conditions were completed in a counterbalanced order (0 and 40 mg/d). After 3 to 5 days of placebo or d-amphetamine maintenance, the participants completed 5 experimental sessions. During these sessions, the participants first sampled the placebo (ie, 4 mg of intranasal cocaine) identified as drug A. The participants then sampled a second intranasal drug dose (4, 10, 20, or 30 mg of cocaine) identified as drug B. The participants then made 6 discrete choices between drugs A and B. Drug choices were separated by 45 minutes. The primary outcome measure was the number of cocaine choices. All doses of cocaine were chosen significantly more than placebo during both maintenance conditions (ie, placebo and d-amphetamine). Choice of the 20-mg dose of cocaine was significantly lower during d-amphetamine maintenance relative to when this cocaine dose was tested during placebo-d-amphetamine maintenance. Cocaine produced prototypical subject-rated drug effects (eg, good effects, like drug, willing to take again). These effects were not altered to a significant degree by d-amphetamine maintenance. Cocaine was well tolerated during D-amphetamine maintenance, and no unexpected or serious adverse events occurred. These results are concordant with those of previous preclinical experiments, human laboratory studies, and clinical trials that suggest that agonist replacement therapy may be a viable strategy for managing cocaine dependence.Keywords
This publication has 32 references indexed in Scilit:
- Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependenceCurrent Opinion in Psychiatry, 2009
- Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine usersDrug and Alcohol Dependence, 2007
- Pharmacotherapy and other treatments for cocaine abuse and dependenceCurrent Opinion in Psychiatry, 2005
- Pharmacologic management of relapse prevention in addictive disordersPsychiatric Clinics of North America, 2004
- Clinical Implications of Reinforcement as a Determinant of Substance Use DisordersAnnual Review of Psychology, 2004
- Voucher-based incentivesAddictive Behaviors, 2002
- A dose response study of cognitive behavioral therapy in cocaine abusersJournal of Substance Abuse Treatment, 2002
- Pharmacological treatment of cocaine dependence: a systematic reviewAddiction, 2002
- Nicotine Medications for Smoking CessationNew England Journal of Medicine, 1995
- Substitution Pharmacotherapies for Opioid Addiction: From Methadone to LAAM and BuprenorphineJournal of Psychoactive Drugs, 1994